Novel Approaches to Postnatal Prophylaxis to Eliminate Vertical Transmission of HIV

The Blind Spot of Pharmacology: A Scoping Review of Drug Metabolism in Prematurely Born Children

(2022) Mette Louise Mørk et al.   Frontiers in Pharmacology

HIV viral load non-suppression and associated factors among pregnant and postpartum women in rural northeastern South Africa: a cross-sectional survey

(2022) Nobubelo Kwanele Ngandu et al.   BMJ Open

Pharmacokinetics, safety, tolerability, and antiviral activity of dolutegravir dispersible tablets in infants and children with HIV-1 (IMPAACT P1093): results of an open-label, phase 1–2 trial

(2022) Theodore D Ruel et al.   Lancet HIV

Characterization of HIV infection in cisgender men and transgender women who have sex with men receiving injectable cabotegravir for HIV prevention: HPTN 083

(2021) Mark A Marzinke et al.   JOURNAL OF INFECTIOUS DISEASES

Safety, Tolerability, and Pharmacokinetics of a Long-Acting Broadly Neutralizing HIV-1 Monoclonal Antibody VRC01LS in HIV-1-Exposed Newborn Infants

(2021) Elizabeth J McFarland et al.   JOURNAL OF INFECTIOUS DISEASES

Eliminating postnatal HIV transmission in high incidence areas: need for complementary biomedical interventions

(2021) Philippe Van de Perre et al.   LANCET

Two Randomized Trials of Neutralizing Antibodies to Prevent HIV-1 Acquisition

(2021) Lawrence Corey et al.   NEW ENGLAND JOURNAL OF MEDICINE

Cabotegravir for HIV Prevention in Cisgender Men and Transgender Women

(2021) Raphael J. Landovitz et al.   NEW ENGLAND JOURNAL OF MEDICINE

Pharmacokinetics and Safety of the Abacavir/Lamivudine/Lopinavir/Ritonavir Fixed-Dose Granule Formulation (4-in-1) in Neonates: PETITE Study

(2021) Adrie Bekker et al.   JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES

Abacavir dosing in neonates from birth to 3 months of life: a population pharmacokinetic modelling and simulation study

(2021) Adrie Bekker et al.   Lancet HIV

Raltegravir (RAL) in neonates

(2020) Diana F. Clarke et al.   JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES

Single-dose bNAb cocktail or abbreviated ART post-exposure regimens achieve tight SHIV control without adaptive immunity

(2020) Mariya B. Shapiro et al.   Nature Communications

Perinatal antiretroviral intensification to prevent intrapartum HIV transmission when antenatal antiretroviral therapy is initiated less than 8 weeks prior to delivery.

(2020) Marc Lallemant et al.   JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES

Pharmacokinetics and safety of early nevirapine-based antiretroviral therapy for neonates at high risk for perinatal HIV infection: a phase 1/2 proof of concept study

(2020) Theodore D Ruel et al.   Lancet HIV

Prevention of perinatal hepatitis B virus transmission

(2019) Ka Wang Cheung et al.   ARCHIVES OF GYNECOLOGY AND OBSTETRICS

Safety, Tolerability, and Pharmacokinetics of the Broadly Neutralizing HIV-1 Monoclonal Antibody VRC01 in HIV-Exposed Newborn Infants

(2019) Coleen K Cunningham et al.   JOURNAL OF INFECTIOUS DISEASES

Cost-effectiveness of integrating postpartum antiretroviral therapy and infant care into maternal & child health services in South Africa

(2019) Caitlin M. Dugdale et al.   PLoS One

Immunological mechanisms of inducing HIV immunity in infants

(2019) Genevieve G. Fouda et al.   VACCINE

Prevention of HIV-1 Transmission Through Breastfeeding

(2018) Patricia M. Flynn et al.   JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES

HIV viraemia and mother-to-child transmission risk after antiretroviral therapy initiation in pregnancy in Cape Town, South Africa

(2016) L Myer et al.   HIV MEDICINE

Extended pre-exposure prophylaxis with lopinavir–ritonavir versus lamivudine to prevent HIV-1 transmission through breastfeeding up to 50 weeks in infants in Africa (ANRS 12174): a randomised controlled trial

(2016) Nicolas Nagot et al.   LANCET

Randomized noninferiority trial of two maternal single-dose nevirapine-sparing regimens to prevent perinatal HIV in Thailand

(2015) Marc Lallemant et al.   AIDS

Dolutegravir: A New Integrase Strand Transfer Inhibitor for the Treatment of HIV

(2013) Bhavik M. Shah et al.   PHARMACOTHERAPY

Lopinavir/Ritonavir versus Lamivudine peri-exposure prophylaxis to prevent HIV-1 transmission by breastfeeding: the PROMISE-PEP trial Protocol ANRS 12174

(2012) Nicolas Nagot et al.   BMC INFECTIOUS DISEASES

Nevirapine versus Ritonavir-Boosted Lopinavir for HIV-Infected Children

(2012) Avy Violari et al.   NEW ENGLAND JOURNAL OF MEDICINE

Antiretroviral Prophylaxis for HIV Prevention in Heterosexual Men and Women

(2012) Jared M. Baeten et al.   NEW ENGLAND JOURNAL OF MEDICINE

Efficacy and safety of an extended nevirapine regimen in infant children of breastfeeding mothers with HIV-1 infection for prevention of postnatal HIV-1 transmission (HPTN 046): a randomised, double-blind, placebo-controlled trial

(2011) Hoosen M Coovadia et al.   LANCET

Maternal or Infant Antiretroviral Drugs to Reduce HIV-1 Transmission

(2010) Charles S. Chasela et al.   NEW ENGLAND JOURNAL OF MEDICINE

Extended Antiretroviral Prophylaxis to Reduce Breast-Milk HIV-1 Transmission

(2008) Newton I. Kumwenda et al.   NEW ENGLAND JOURNAL OF MEDICINE

Early mixed feeding and breastfeeding beyond 6 months increase the risk of postnatal HIV transmission: ANRS 1201/1202 Ditrame Plus, Abidjan, Côte d'Ivoire

(2007) Renaud Becquet et al.   PREVENTIVE MEDICINE